[Form 4] Petco Health and Wellness Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

On 1 Aug 2025, Petco Health & Wellness (WOOF) CEO/director Joel D. Anderson purchased 1,100 Class A shares at $2.48 through the company’s 2021 Employee Stock Purchase Plan, a transaction exempt under Rule 16b-3.

Post-purchase, Anderson’s direct stake is 3,226,281 shares, comprising 2,712,719 RSUs plus 513,562 unrestricted shares. He also reports indirect holdings of 853,304 shares (2020 Trust), 724,910 shares (2025 Trust) and 7,874 shares held by his son. No derivative securities were bought or sold.

The added shares increase his total beneficial ownership marginally—about 0.04 % of his direct position—but insider buys generally signal management confidence and may be viewed positively by investors.

Insights

Financial Analyst

TL;DR: Small insider buy; positive signal but quantitatively immaterial, impact neutral-to-slight positive.

The CEO’s $2.7k purchase under the ESPP is dwarfed by his existing 3.2 m-share stake, so the economic commitment is minimal. Still, Form 4 shows he is adding, not trimming, and reports no new option exercises or sales. With >2.7 m RSUs outstanding, future dilution from vesting is already disclosed. Overall effect on valuation or float is negligible; however, the directional cue is modestly constructive for sentiment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anderson Joel D

(Last) (First) (Middle)

C/O PETCO HEALTH AND WELLNESS COMPANY,

INC., 10850 VIA FRONTERA

(Street)

SAN DIEGO CA 92127

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Petco Health & Wellness Company, Inc. [ WOOF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/01/2025		A(1)	V	1,100	A	$2.48	3,226,281(2)	D
Class A Common Stock								853,304	I	By 2020 Trust
Class A Common Stock								724,910	I	By 2025 Trust
Class A Common Stock								7,874	I	By son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares of Class A common stock of the Issuer were acquired under the Petco Health and Wellness Company, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

2. Includes 2,712,719 outstanding restricted stock units ("RSUs") granted under the Petco Health and Wellness Company, Inc. 2021 Equity Incentive Plan. Each RSU represents the right to receive one share of Class A common stock of the Issuer.

	/s/ Giovanni Insana, as Attorney-in-Fact	08/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Petco (WOOF) shares did CEO Joel D. Anderson buy on 1 Aug 2025?

He acquired 1,100 Class A shares.

What was the purchase price disclosed in the Form 4?

Shares were bought at $2.48 each via the Employee Stock Purchase Plan.

What is the CEO’s total direct ownership after the transaction?

Anderson now directly holds 3,226,281 shares, including RSUs.

Were any derivative securities reported in this filing?

No; Table II shows no derivative transactions.

How many restricted stock units are included in the CEO’s holdings?

The filing notes 2,712,719 RSUs within his direct stake.